Loading...
Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration‐resistant prostate cancer models
Previous studies have shown that increased levels of chemokine receptor CXCR7 are associated with the increased invasiveness of prostate cancer cells. We now show that CXCR7 expression is upregulated in VCaP and C4‐2B cells after enzalutamide (ENZ) treatment. ENZ treatment induced apoptosis (sub‐G1)...
Na minha lista:
| Udgivet i: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5867246/ https://ncbi.nlm.nih.gov/pubmed/29277895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31237 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|